Beneficient Receives Additional Nasdaq Listing Determination
Beneficient (NASDAQ: BENF) has received an additional delisting notice from Nasdaq due to delayed filing of its Q2 2025 Form 10-Q. This follows previous notifications regarding non-compliance with the $1.00 minimum bid price requirement and delayed filing of FY2025 Form 10-K.
The company has requested a hearing before the Nasdaq Hearings Panel to present its compliance plan and seek an extension. While Beneficient is taking steps to address these issues, there is no guarantee the Panel will approve continued listing.
Beneficient (NASDAQ: BENF) ha ricevuto un ulteriore avviso di revoca dalla quotazione da parte del Nasdaq a causa del ritardo nella presentazione del suo Modulo 10-Q relativo al secondo trimestre 2025. Questo si aggiunge a precedenti notifiche per il mancato rispetto del requisito del prezzo minimo per azione di $1,00 e per il ritardo nella presentazione del Modulo 10-K per l'esercizio 2025.
L'azienda ha chiesto un'audizione davanti al Nasdaq Hearings Panel per illustrare il proprio piano di conformit脿 e richiedere una proroga. Sebbene Beneficient stia adottando misure per risolvere le problematiche, non vi 猫 alcuna garanzia che il Panel approvi il mantenimento della quotazione.
Beneficient (NASDAQ: BENF) ha recibido una notificaci贸n adicional de exclusi贸n por parte de Nasdaq debido a la presentaci贸n tard铆a de su Formulario 10-Q del segundo trimestre de 2025. Esto se suma a avisos previos por incumplimiento del requisito de precio m铆nimo por acci贸n de $1.00 y por el retraso en la presentaci贸n del Formulario 10-K del a帽o fiscal 2025.
La compa帽铆a ha solicitado una audiencia ante el Nasdaq Hearings Panel para exponer su plan de cumplimiento y solicitar una pr贸rroga. Aunque Beneficient est谩 tomando medidas para corregir los problemas, no hay garant铆a de que el Panel apruebe la continuidad de la cotizaci贸n.
Beneficient (NASDAQ: BENF)電� 2025雲� 2攵勱赴 攵勱赴氤搓碃靹�(Form 10-Q) 鞝滌稖 歆�鞐办溂搿� 鞚疙暣 雮橃姢雼レ溂搿滊秬韯� 於旉皜 靸侅灔韽愳 韱奠毳� 氚涭晿鞀惦媹雼�. 鞚措姅 欤茧嫻 斓滌唽 毵れ瀰臧�瓴� $1.00 鞖旉贝 氙胳订臁� 氚� 2025 須岅硠鞐半弰 鞐办皑氤搓碃靹�(Form 10-K) 歆�鞐� 鞝滌稖鞐� 雽�頃� 鞚挫爠 韱奠鞐� 霐半ジ 瓴冹瀰雼堧嫟.
須岇偓電� 雮橃姢雼� 鞁Μ韺剱(Nasdaq Hearings Panel)鞐� 鞁Μ毳� 鞖旍箔頃� 欷�靾� 瓿勴殟鞚� 鞝滌稖頃橁碃 鞐办灔 項堦皜毳� 甑枅鞀惦媹雼�. Beneficient臧� 氍胳牅 頃搓舶鞚� 鞙勴暣 臁办箻毳� 旆晿瓿犽姅 鞛堨毵�, 韺剱鞚� 靸侅灔 鞙犾 鞀轨澑鞚� 頃� 瓴冹澊霛茧姅 氤挫灔鞚� 鞐嗢姷雼堧嫟.
Beneficient (NASDAQ: BENF) a re莽u un avis suppl茅mentaire de radiation de la part du Nasdaq en raison du d茅p么t tardif de son formulaire 10-Q pour le deuxi猫me trimestre 2025. Cela s'ajoute 脿 des notifications pr茅c茅dentes concernant le non-respect de l'exigence du prix minimum par action de 1,00 $ et le d茅p么t tardif du formulaire 10-K pour l'exercice 2025.
La soci茅t茅 a demand茅 une audition devant le Nasdaq Hearings Panel pour pr茅senter son plan de conformit茅 et solliciter une extension. Bien que Beneficient prenne des mesures pour rem茅dier 脿 ces probl猫mes, rien ne garantit que le Panel approuve le maintien de la cotation.
Beneficient (NASDAQ: BENF) hat von der Nasdaq eine weitere Delisting-Mitteilung erhalten, weil die Einreichung des Quartalsberichts Form 10-Q f眉r Q2 2025 versp盲tet erfolgt ist. Dies kommt zus盲tzlich zu fr眉heren Hinweisen wegen Nichteinhaltung der Mindestnotierungspreisanforderung von $1,00 und der versp盲teten Einreichung des Gesch盲ftsberichts Form 10-K f眉r das Gesch盲ftsjahr 2025.
Das Unternehmen hat eine Anh枚rung vor dem Nasdaq Hearings Panel beantragt, um seinen Compliance-Plan vorzustellen und eine Fristverl盲ngerung zu erwirken. Zwar ergreift Beneficient Ma脽nahmen zur Behebung der Probleme, doch gibt es keine Garantie daf眉r, dass das Panel die Fortf眉hrung der Notierung genehmigt.
- None.
- Received additional Nasdaq delisting notice for delayed Q2 2025 10-Q filing
- Non-compliance with $1.00 minimum bid price requirement
- Delayed filing of FY2025 Form 10-K
- Risk of potential delisting from Nasdaq
Insights
Beneficient faces serious delisting risk from Nasdaq due to multiple compliance failures, creating significant uncertainty for investors.
Beneficient is now contending with three separate Nasdaq compliance issues, significantly elevating the risk of delisting. The company has failed to meet the minimum $1.00 bid price requirement and has delayed filing both its annual 10-K (fiscal year ended March 31, 2025) and now its quarterly 10-Q (quarter ended June 30, 2025).
These multiple violations represent a serious regulatory predicament. Late financial filings often signal underlying accounting complexities or potential governance issues that warrant investor caution. The company has requested a hearing before the Nasdaq Hearings Panel to present a compliance plan and seek an extension, but the press release explicitly acknowledges there is "no assurance" that Beneficient's request will be granted.
The confluence of reporting delays with the bid price deficiency creates a particularly challenging situation. While companies can often address a single compliance issue through reverse splits or other remedial actions, multiple simultaneous violations substantially complicate the path to continued listing. If delisted, Beneficient would likely move to the OTC markets, where stocks typically experience reduced liquidity, less analyst coverage, decreased institutional investment, and potentially lower valuations.
The company's statement that it is taking "definitive steps" to address compliance issues lacks specificity and provides little concrete reassurance about the likelihood of maintaining its Nasdaq listing. The repeated failure to meet filing deadlines suggests potential underlying operational or financial reporting problems that may extend beyond mere technical compliance issues.
DALLAS, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ: BENF) (the 鈥淐ompany鈥�), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets through its proprietary online platform AltAccess, today announced that on August 18, 2025, the Company was notified by The Nasdaq Stock Market LLC (鈥淣asdaq鈥�) that, the delay in the filing of the Company鈥檚 Quarterly Report on Form 10-Q for the quarter ended June 30, 2025 with the Securities and Exchange Commission (the 鈥淪EC鈥�), in contravention of Nasdaq鈥檚 periodic reporting requirement set forth in Nasdaq Listing Rule 5250(c)(1), served as an additional basis for delisting from The Nasdaq Capital Market.
As previously disclosed, the Company previously received a notification from Nasdaq that due to its continued non-compliance with the minimum
The Company timely requested a hearing before the Nasdaq Hearings Panel (the 鈥淧anel鈥�), at which the Company will present its plan to evidence compliance with all applicable criteria for continued listing on The Nasdaq Capital Market and request an extension of time to do so. While the Company is taking definitive steps to evidence compliance with the applicable listing criteria as soon as practicable, there can be no assurance that the Panel will grant the Company鈥檚 request for continued listing on Nasdaq.
About Beneficient
Beneficient (Nasdaq: BENF) 鈥� Ben, for short 鈥� is on a mission to democratize the global alternative asset investment market by providing traditionally underserved investors 鈭� mid-to-high net worth individuals, small-to-midsized institutions鈥痑nd General Partners seeking exit options, anchor commitments and valued-added services for their funds鈭� with solutions that could help them unlock the value in their alternative assets. Ben鈥檚 AltQuote庐 tool provides customers with a range of potential exit options within minutes, while customers can log on to the AltAccess庐 portal to explore opportunities and receive proposals in a secure online environment.
Its subsidiary, Beneficient Fiduciary Financial, L.L.C., received its charter under the State of Kansas鈥� Technology-Enabled Fiduciary Financial Institution (TEFFI) Act and is subject to regulatory oversight by the Office of the State Bank Commissioner.
For more information, visit www.trustben.com or follow us on LinkedIn.
Contacts
Matt Kreps: 214-597-8200, [email protected]
Michael Wetherington: 214-284-1199, [email protected]
Investor Relations: [email protected]
Forward Looking Statements
This press release contains forward-looking statements within the meaning of the 鈥渟afe harbor鈥� provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements regarding the listing and trading of the Company鈥檚 securities on Nasdaq, the Company鈥檚 intention to request a hearing from the Nasdaq hearing panel and the Company鈥檚 intention to regain compliance with the Nasdaq Listing Rules. The words 鈥渁nticipate,鈥� 鈥渂elieve,鈥� 鈥渃ontinue,鈥� 鈥渃ould,鈥� 鈥渆stimate,鈥� 鈥渆xpect,鈥� 鈥渋ntends,鈥� 鈥渕ay,鈥� 鈥渕ight,鈥� 鈥減lan,鈥� 鈥減ossible,鈥� 鈥減otential,鈥� 鈥減redict,鈥� 鈥減roject,鈥� 鈥渟hould,鈥� 鈥渨ould鈥� and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements are based on our management鈥檚 beliefs, as well as assumptions made by, and information currently available to, them. Because such statements are based on expectations as to future financial and operating results and are not statements of fact, actual results may differ materially from those projected.
Important factors that could cause actual results to differ materially from those expressed in the forward-looking statements include, among others, our plans to appeal Nasdaq鈥檚 delisting determination; the outcome of the hearing; our ability to cure any deficiencies in compliance with the Nasdaq Listing Rules; risks related to the substantial costs and diversion of management鈥檚 attention and resources due to these matters and the risks, uncertainties, and factors set forth under 鈥淩isk Factors鈥� in the Company鈥檚 most recent Annual Report on Form 10-K and its subsequently filed Quarterly Reports on Form 10-Q and the risks and uncertainties contained in the Company鈥檚 Current Reports on Form 8-K. Forward-looking statements speak only as of the date they are made. The Company assumes no obligation to update forward-looking statements to reflect actual results, subsequent events, or circumstances or other changes affecting such statements except to the extent required by applicable law.
Forward-looking statements speak only as of the date they are made. Readers are cautioned not to put undue reliance on forward-looking statements, and, except as required by law, the Company assumes no obligation and does not intend to update or revise these forward-looking statements, whether as a result of new information, future events, or otherwise.
FAQ
Why is Beneficient (BENF) facing potential delisting from Nasdaq in 2025?
What steps is BENF taking to maintain its Nasdaq listing in 2025?
When did Nasdaq issue the latest delisting notice to Beneficient (BENF)?
What are the specific Nasdaq listing rules that BENF has violated?
